跳至主要内容
临床试验/NCT01154244
NCT01154244已完成不适用

Insulin Resistance as Primary Pathogenesis in Newly Diagnosed, Drug naïve Type 2 Diabetes Patients in Korea

GlaxoSmithKline1 个研究点 分布在 1 个国家目标入组 1,439 人开始时间: 2009年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,439
试验地点
1
主要终点
insulin resistance assessed using HOMA-IR

研究概览

简要总结

The purpose of this study is investigating the clinical characteristics of newly diagnosed, drug naïve type 2 diabetic patients according to insulin secretion and insulin resistance.

详细描述

Primary Objective:To investigate whether insulin resistance or insulin deficiency is primary in the pathogenesis of type 2 diabetes mellitus in Korea Secondary Objectives:To investigate proportion of patients with severe insulin deficiency at diagnosis,To investigate proportion of metabolic syndrome in patients with newly diagnosed, drug-naïve type 2 diabetes mellitus,To investigate proportion of obesity in patients with newly diagnosed, drug-naïve type 2 diabetes mellitus

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Newly diagnosed, drug naïve type 2 DM patients who gave informed consent, Diagnosis of type 2 DM will be made according to ADA guideline 2009

排除标准

  • Patients age under 18 years

结局指标

主要结局

insulin resistance assessed using HOMA-IR

时间窗: within 3months after DM diagnosis

次要结局

  • proportion of patients with severe insulin deficiency assessed using C-peptide(within 3months after DM diagnosis)
  • proportion of metabolic syndrome in patients(within 3months after DM diagnosis)
  • proportion of obesity in patients(within 3months after DM diagnosis)

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验